text:
<?php

/**
 * This is the model class for table "News".
 *
 * The followings are the available columns in table 'News':
 * @property integer $id
 * @property string $create_time
 * @property string $update_time
 * @property string $date
 * @property string $title
 * @property string $slug
 * @property string $short_text
 * @property string $full_text
 * @property integer $user_id
 * @property integer $status
 * @property integer $is_protected
 * @property string  $link
 * @property string  $image
 * @property string $description
 * @property string $keywords
 */
class News extends yupe\models\YModel
{
    const STATUS_DRAFT = 0;
    const STATUS_PUBLISHED = 1;
    const STATUS_MODERATION = 2;

    const PROTECTED_NO = 0;
    const PROTECTED_YES = 1;

    /**
     * @return string the associated database table name
     */
    public function tableName()
    {
        return '{{news_news}}';
    }

    /**
     * Returns the static model of the specified AR class.
     * @param  string $className
     * @return News   the static model class
     */
    public static function model($className = __CLASS__)
    {
        return parent::model($className);
    }

    /**
     * @return array validation rules for model attributes.
     */
    public function rules()
    {
        return [
            ['title, slug, short_text, full_text, keywords, description', 'filter', 'filter' => 'trim'],
            ['title, slug, keywords, description', 'filter', 'filter' => [new CHtmlPurifier(), 'purify']],
            ['date, title, slug, full_text', 'required', 'on' => ['update', 'insert']],
            ['status, is_protected, category_id', 'numerical', 'integerOnly' => true],
            ['title, slug, keywords', 'length', 'max' => 150],
            ['lang', 'length', 'max' => 2],
            ['lang', 'default', 'value' => Yii::app()->sourceLanguage],
            ['lang', 'in', 'range' => array_keys(Yii::app()->getModule('yupe')->getLanguagesList())],
            ['status', 'in', 'range' => array_keys($this->getStatusList())],
            ['slug', 'yupe\components\validators\YUniqueSlugValidator'],
            ['description', 'length', 'max' => 250],
            ['link', 'length', 'max' => 250],
            ['link', 'yupe\components\validators\YUrlValidator'],
            [
                'slug',
                'yupe\components\validators\YSLugValidator',
                'message' => Yii::t('NewsModule.news', 'Bad characters in {attribute} field')
            ],
            ['category_id', 'default', 'setOnEmpty' => true, 'value' => null],
            [
                'id, keywords, description, create_time, update_time, date, title, slug, short_text, full_text, user_id, status, is_protected, lang',
                'safe',
                'on' => 'search'
            ],
        ];
    }

    public function behaviors()
    {
        $module = Yii::app()->getModule('news');

        return [
            'imageUpload' => [
                'class'         => 'yupe\components\behaviors\ImageUploadBehavior',
                'attributeName' => 'image',
                'minSize'       => $module->minSize,
                'maxSize'       => $module->maxSize,
                'types'         => $module->allowedExtensions,
                'uploadPath'    => $module->uploadPath,
            ],
        ];
    }

    /**
     * @return array relational rules.
     */
    public function relations()
    {
        return [
            'category' => [self::BELONGS_TO, 'Category', 'category_id'],
            'user'     => [self::BELONGS_TO, 'User', 'user_id'],
        ];
    }

    public function scopes()
    {
        return [
            'published' => [
                'condition' => 't.status = :status',
                'params'    => [':status' => self::STATUS_PUBLISHED],
            ],
            'protected' => [
                'condition' => 't.is_protected = :is_protected',
                'params'    => [':is_protected' => self::PROTECTED_YES],
            ],
            'public'    => [
                'condition' => 't.is_protected = :is_protected',
                'params'    => [':is_protected' => self::PROTECTED_NO],
            ],
            'recent'    => [
                'order' => 'create_time DESC',
                'limit' => 5,
            ]
        ];
    }

    public function last($num)
    {
        $this->getDbCriteria()->mergeWith(
            [
                'order' => 'date DESC',
                'limit' => $num,
            ]
        );

        return $this;
    }

    public function language($lang)
    {
        $this->getDbCriteria()->mergeWith(
            [
                'condition' => 'lang = :lang',
                'params'    => [':lang' => $lang],
            ]
        );

        return $this;
    }

    public function category($category_id)
    {
        $this->getDbCriteria()->mergeWith(
            [
                'condition' => 'category_id = :category_id',
                'params'    => [':category_id' => $category_id],
            ]
        );

        return $this;
    }

    /**
     * @return array customized attribute labels (name=>label)
     */
    public function attributeLabels()
    {
        return [
            'id'            => Yii::t('NewsModule.news', 'Id'),
            'category_id'   => Yii::t('NewsModule.news', 'Category'),
            'create_time' => Yii::t('NewsModule.news', 'Created at'),
            'update_time'   => Yii::t('NewsModule.news', 'Updated at'),
            'date'          => Yii::t('NewsModule.news', 'Date'),
            'title'         => Yii::t('NewsModule.news', 'Title'),
            'slug'         => Yii::t('NewsModule.news', 'Alias'),
            'image'         => Yii::t('NewsModule.news', 'Image'),
            'link'          => Yii::t('NewsModule.news', 'Link'),
            'lang'          => Yii::t('NewsModule.news', 'Language'),
            'short_text'    => Yii::t('NewsModule.news', 'Short text'),
            'full_text'     => Yii::t('NewsModule.news', 'Full text'),
            'user_id'       => Yii::t('NewsModule.news', 'Author'),
            'status'        => Yii::t('NewsModule.news', 'Status'),
            'is_protected'  => Yii::t('NewsModule.news', 'Access only for authorized'),
            'keywords'      => Yii::t('NewsModule.news', 'Keywords (SEO)'),
            'description'   => Yii::t('NewsModule.news', 'Description (SEO)'),
        ];
    }

    public function beforeValidate()
    {
        if (!$this->slug) {
            $this->slug = yupe\helpers\YText::translit($this->title);
        }

        if (!$this->lang) {
            $this->lang = Yii::app()->getLanguage();
        }

        return parent::beforeValidate();
    }

    public function beforeSave()
    {
        $this->update_time = new CDbExpression('NOW()');
        $this->date = date('Y-m-d', strtotime($this->date));

        if ($this->isNewRecord) {
            $this->create_time = $this->update_time;
            $this->user_id = Yii::app()->getUser()->getId();
        }

        return parent::beforeSave();
    }

    public function afterFind()
    {
        $this->date = date('d-m-Y', strtotime($this->date));

        return parent::afterFind();
    }

    /**
     * Retrieves a list of models based on the current search/filter conditions.
     * @return CActiveDataProvider the data provider that can return the models based on the search/filter conditions.
     */
    public function search()
    {
        // Warning: Please modify the following code to remove attributes that
        // should not be searched.

        $criteria = new CDbCriteria();

        $criteria->compare('t.id', $this->id);
        $criteria->compare('create_time', $this->create_time, true);
        $criteria->compare('update_time', $this->update_time, true);
        if ($this->date) {
            $criteria->compare('date', date('Y-m-d', strtotime($this->date)));
        }
        $criteria->compare('title', $this->title, true);
        $criteria->compare('t.slug', $this->slug, true);
        $criteria->compare('short_text', $this->short_text, true);
        $criteria->compare('full_text', $this->full_text, true);
        $criteria->compare('user_id', $this->user_id);
        $criteria->compare('t.status', $this->status);
        $criteria->compare('category_id', $this->category_id, true);
        $criteria->compare('is_protected', $this->is_protected);
        $criteria->compare('t.lang', $this->lang);
        $criteria->with = ['category'];

        return new CActiveDataProvider(get_class($this), [
            'criteria' => $criteria,
            'sort'     => ['defaultOrder' => 'date DESC'],
        ]);
    }

    public function getStatusList()
    {
        return [
            self::STATUS_DRAFT      => Yii::t('NewsModule.news', 'Draft'),
            self::STATUS_PUBLISHED  => Yii::t('NewsModule.news', 'Published'),
            self::STATUS_MODERATION => Yii::t('NewsModule.news', 'On moderation'),
        ];
    }

    public function getStatus()
    {
        $data = $this->getStatusList();

        return isset($data[$this->status]) ? $data[$this->status] : Yii::t('NewsModule.news', '*unknown*');
    }

    public function getProtectedStatusList()
    {
        return [
            self::PROTECTED_NO  => Yii::t('NewsModule.news', 'no'),
            self::PROTECTED_YES => Yii::t('NewsModule.news', 'yes'),
        ];
    }

    public function getProtectedStatus()
    {
        $data = $this->getProtectedStatusList();

        return isset($data[$this->is_protected]) ? $data[$this->is_protected] : Yii::t('NewsModule.news', '*unknown*');
    }

    public function getCategoryName()
    {
        return ($this->category === null) ? '---' : $this->category->name;
    }

    public function getFlag()
    {
        return yupe\helpers\YText::langToflag($this->lang);
    }

    /**
     * @deprecated
     * @return mixed
     */
    public function getPermaLink()
    {
        return $this->getUrl();
    }
}


Let's enjoy a day on board of Solemio ! All included, open bar! Just relax and enjoy!
Great experience! Super organized. Friendly staff, good quality of food, drinks and service. Perfect day trip!
Amazing boat ride, amazing food, amazing drinks, amazing people!
A wonderful crew, an amazing journey on the boat, a great great food AND really really a day i Will remember all my life. Thank you solemio IT was just incredible !!!!!
Excellent boat trip in Pipa!!!
The trip is excellent! Very well organized, and very friendly crew! You have free food and beverage on board, all of the highest quality! Very good value for money. I recommend this tour and I´ll do it again!!!
Get quick answers from Passeio de Barco Lagoa das Guarairas staff and past visitors.


text:
Harbor Capital Advisors Launches Disruptive Innovation ETF
CHICAGO — December 2, 2021 — Harbor Capital Advisors, Inc. ("Harbor"), a premier investment firm offering access to specialized expertise across a range of investment strategies and vehicles, today launched the Harbor Disruptive Innovation ETF.
Managed by Harbor's Multi-Asset Solutions Team, the Harbor Disruptive Innovation ETF (INNO) utilizes an actively managed multi-strategy approach to offer exposure to innovative companies displacing pre-existing goods, services, and industry leaders across sectors, market capitalizations and regions.
Through its rigorous manager due diligence, Harbor has selected a network of specialized asset managers to contribute concentrated equity allocations to the Disruptive Innovation portfolio. Harbor determines the allocations to the underlying asset managers with the goal of maximizing the portfolio's diversification benefits and managing risk. INNO is a fully transparent ETF that discloses daily holdings.
This is the third actively-managed, fully transparent ETF introduced by Harbor. In September, Harbor made its debut in the ETF market with two fixed-income ETFs — Harbor Scientific Alpha High-Yield ETF (SIHY) and Harbor Scientific Alpha Income ETF (SIFI).
"Harbor is excited to expand its ETF offering with the launch of a strategy that's purpose-built to unlock the opportunities in disruptive innovation," said Spenser Lerner, Portfolio Manager and Head of Multi-Asset Solutions, Harbor.
"Through our Disruptive Innovation strategy, we seek to offer investors access to businesses that are transforming the marketplace, while mitigating risk by carefully managing the exposures of the overall portfolio. We believe our multi-strategy framework is highly differentiated. Our process allows us to access disruptive trends across markets, help maximize the alpha potential of concentrated and specialized managers, and seek to mitigate risk through our proprietary portfolio construction methodology," said Lerner.
Key Features of the Harbor Disruptive Innovation ETF (INNO)
An actively managed and fully transparent multi-strategy ETF with a differentiated approach to accessing disruptive innovation, the Fund leverages the investment experience of specialized managers and places portfolio construction and risk management front and center.
Harbor employs a multi-strategy approach and allocates across five different active managers with unique investment styles offering philosophical, style, and sector diversification. They are exceptional stock pickers, and this approach seeks to enhance investors' opportunity set by investing in leading edge, industry transforming companies across sectors, market cap ranges, and regions.
Harbor is responsible for portfolio construction and risk management with the goal of maximizing diversification benefits of the underlying managers and minimizing concentrated factor exposures.
The strategy's underlying managers possess competitive advantages in selecting securities, while Harbor has distinct advantage in conducting portfolio construction and risk management. Harbor Disruptive Innovation enables both groups to concentrate on their respective core competencies.
Disruptive Innovation Strategy Profile
About Harbor
Harbor offers a diverse family of cost-aware investment solutions managed by institutional-caliber firms. We source talented investment teams to manage portfolios and apply a rigorous fiduciary oversight program to monitor their performance and investment decisions. Harbor had combined assets under management of approximately $63 billion as of September 30, 2021. For more information, visit harborcapital.com.
BEFORE INVESTING YOU SHOULD CAREFULLY CONSIDER A FUND'S INVESTMENT OBJECTIVES, RISKS, CHARGES, AND EXPENSES. THIS AND OTHER INFORMATION IS IN THE PROSPECTUS. PLEASE READ THE PROSPECTUS CAREFULLY BEFORE YOU INVEST. TO OBTAIN A SUMMARY PROSPECTUS OR PROSPECTUS FOR THIS AND OTHER INFORMATION, VISIT HARBORCAPITAL.COM OR CALL 800-422-1050.
There is no guarantee that the investment objective of the Fund will be achieved. Stock markets are volatile and equity values can decline significantly in response to adverse issuer, political, regulatory, market and economic conditions. Since the Fund may hold foreign securities, it may be subject to greater risks than funds invested only in the U.S. These risks are more severe for securities issuers in emerging market regions. Investing in REITs will subject the Fund to additional risk. Foreside Fund Services, LLC is the Distributor of the Harbor ETF Trust and the Harbor Disruptive Innovation ETF.
Unlike mutual funds, ETFs may trade at a premium or discount to their net asset value. The ETFs is new and has limited operating history to judge.
Download this Press Release as a PDF
Harbor Disruptive Innovation ETF

redpajama_set_name: RedPajamaCommonCrawl


You know that window tinting is capable of providing your home, business, or vehicle with a whole range of benefits. This is one of the reasons why you have finally decided to get some for your car, office, or home. However, you might not have any idea where to begin. Fortunately, this short article will provide you all there is to know about window tinting and availing of window tinting services from the professionals.
One of the things that you need to know about window tinting is that you should hire a professional for the job. You see, you can only fully enjoy the benefits that window tinting has to offer when you have it installed by the professionals. If you miss this step out, then you will most likely regret not hiring the right people for the job.
So, how do you choose the right window tinting company for the job? With the increasing demand for window tints, it is not surprising why there are also many companies that offer these services. Before you choose the first window tinting company that you see, though, you have to take a few things into careful consideration. Basically, you begin by taking the time out of your schedule to do some research work on the potential companies that you can hire. Determine how long they have been working in the business. Read reviews that are posted online about them and check their website in order for you to determine what other services they offer aside from window tinting. Keep in mind that there are different kinds of window tinting services that you can avail, each specific to your needs. These include auto window tinting, residential window tinting, and commercial window tinting services. If you know of some people around you who have tried availing of these services and are satisfied with them, make sure to get the names of the auto window tinting companies that they have tried hiring. After you have obtained a list of possible companies that you can hire, proceed to give each of them a call. If they are professionals in answering your call and your questions, you know that you are in the right direction.
Once you have found the right window tinting Johns Creek company to hire, you then proceed to decide what kind of window film you should be getting. Tinting films are offered in different strengths, colors, and qualities. Each will vary depending on the manufacturer. While some window films cost you more, if they are made of high-quality materials, you know that they are durable and can last you a long time. You may have to get in touch with the window tinting professional that you hire to know of your window tinting options.
At https://en.wikipedia.org/wiki/One-way_mirror you could find other related stories.
A lot of people have been tinting their windows and if you are thinking about it too then this article is going to be of huge help to you. This article is going to answer important questions that you have on your mind right now especially about window tinting.
Choosing the right window tinting company is going to be the key to all of this.
There are a ton of things that you have to consider when it comes to hiring a window tinting company and reputation is always going to be one of it. Make sure that you do a lot of research about the company that you plan on hiring because it is going to be a huge help for choosing the right one. Make sure that you consider how long they have been in the business and always check out the reviews because that is where you will get most of the information you need. You can always ask friends as well as family and co-workers to help you out with choosing the right residential window tinting company to help you out. Once you finally create a short list of the companies that you plan on hiring, make sure to call them one by one and compare their offers. Comparing is going to help you pin point the right company that you will want to help you with the window tinting process.
With a number of people looking for window tints every day, the market has become saturated with window tints and that is actually a pretty common thing when the demand is this high. People who are looking for window tints can't help but have problems finding the right company to install the tint for them because there are not so many window tint companies out there at this time yet. The demand of window tints have led people to change careers and a number of them went to becoming window tint companies which is a pretty good move give the market and the trend of window tints.
If you want to have the finest window tint there is, you better do some researching time and try to locate the best window tint company there is. Never settle for less; do not hire any random company to help you with your window tint needs because that is how you get cheated. Always take the time to rethink your possible decision because window tints are not that cheap as well. Make sure you consider the guide take the time to choose the right window tinting Lawrenceville GA company out there.
You may also take a look at https://www.youtube.com/watch?v=n6DtnABfXF8 if you want to read/watch further.
So, how do you choose the right business window tinting near me for the job? With the increasing demand for window tints, it is not surprising why there are also many companies that offer these services. Before you choose the first window tinting company that you see, though, you have to take a few things into careful consideration. Basically, you begin by taking the time out of your schedule to do some research work on the potential companies that you can hire. Determine how long they have been working in the business. Read reviews that are posted online about them and check their website in order for you to determine what other services they offer aside from window tinting. Keep in mind that there are different kinds of window tinting services that you can avail, each specific to your needs. These include auto window tinting, residential window tinting, and commercial window tinting Marietta GA services. If you know of some people around you who have tried availing of these services and are satisfied with them, make sure to get the names of the window tinting companies that they have tried hiring. After you have obtained a list of possible companies that you can hire, proceed to give each of them a call. If they are professionals in answering your call and your questions, you know that you are in the right direction.
Once you have found the right window tinting company to hire, you then proceed to decide what kind of window film you should be getting. Tinting films are offered in different strengths, colors, and qualities. Each will vary depending on the manufacturer. While some window films cost you more, if they are made of high-quality materials, you know that they are durable and can last you a long time. You may have to get in touch with the window tinting professional that you hire to know of your window tinting options.
Please visit https://www.reference.com/article/tint-windows-878b550ded662da5?aq=window+tint&qo=cdpArticles for a related story.


George J. Atis is the co-founder of the Summit and a leading outsourcing lawyer in Canada. Mr. Atis is also gaining an international reputation as a trusted outsourcing process advisor, having practiced north and south of the 49th parallel and on both sides of the negotiating table (i.e. "client" and "vendor"). Mr. Atis is also the founder and president of Outsourcing-Canada Inc., a legal service and consulting firm dedicated to advising both clients and vendors in preparing and negotiating complex deals — on a no-nonsense, non-self-serving basis.
He is the publisher of the GJA Outsourcing Tool Kit™, the author of several, internationally renowned articles and presentations on the legal and "legal project-management" aspects of outsourcing deals and a frequently-requested speaker. As a pet project, he is developing an online clearing-house of Canadian outsourcing market information and universally applicable and practical documentary forms and precedents for use by clients and vendors through his Web site: www.outsourcing-canada.ca.


Generac is proud to offer the first ever, CSA approved service rated transfer switches for Canadian use. These switches use patent pending technology to allow for use in whole house applications in Canada. The switches are available in 100 and 200 amp ratings for single phase applications.
would like to see wire diagram ?


Chromium deficiency. Taking chromium by mouth is effective for preventing chromium deficiency.
Diabetes. Some evidence shows that taking chromium picolinate (a chemical compound that contains chromium) by mouth, either alone or along with biotin, can lower fasting blood sugar, lower insulin levels, and help insulin work in people with type 2 diabetes. Also, chromium picolinate might decrease weight gain and fat accumulation in people with type 2 diabetes who are taking a class of antidiabetes medications called sulfonylureas.
Higher chromium doses might be more effective and work more quickly. Higher doses might also lower the level of certain blood fats (cholesterol and triglycerides) in some people.
Early research shows that chromium picolinate might have the same benefits in people with type 1 diabetes, people who have diabetes as a result of steroid treatment, and people with diabetes the develops during pregnancy.
However, researchers are looking carefully at the results that show chromium might be effective for treating diabetes. It might not help everyone. Some researchers think that chromium supplements benefit only people with poor nutrition or low chromium levels. Chromium levels can be below normal in people with diabetes. Other researchers think that chromium might only help people with diabetes and insulin resistance.
High levels of cholesterol or other blood fats. Some research shows that taking 15-200 mcg of chromium daily for 6-12 weeks lowers low-density lipoprotein (LDL or "bad") cholesterol and total cholesterol levels in people with slightly high or high cholesterol levels. Other research suggests that taking chromium for 7-16 months lowers triglycerides and LDL, and increases high-density lipoprotein (HDL or "good") cholesterol. Also, taking chromium alone or along with other supplements seems to reduce levels of blood fats in people with high blood fat levels. However, there is some evidence that taking chromium daily for 10 weeks does not improve cholesterol levels in postmenopausal women.
Athletic performance. Some early evidence that shows that taking chromium while participating in resistance training can increase weight loss, body fat loss, and lean body mass. However, most reliable research shows that taking chromium by mouth does not enhance body building, strength, or lean body mass.
Binge eating disorder. Research shows that taking chromium picolinate by mouth daily for 6 months does not affect weight, depression symptoms, or the frequency of binge eating in people with binge eating disorder.
Prediabetes. Most research shows that taking chromium does not help control sugar levels people with prediabetes.
Obesity. There is some conflicting evidence about the effects of chromium on obesity. Some limited research shows that chromium might improve weight loss in some people who are overweight or obese. But the amount of weight loss is probably not clinically significant. Furthermore, most research shows that taking chromium by mouth does not improve weight loss.
Schizophrenia. Research shows that taking 400 mcg of chromium daily for 3 months does not affect weight or mental health in people with schizophrenia.
Age-related mental decline. Research shows that taking 1000 mcg of chromium daily for 12 weeks does not improve memory or depression in older people with mild mental decline. However, images of the brain show that taking chromium can increase some brain activity during memory games.
High blood sugar associated with HIV treatments. Early research shows that taking chromium nicotinate or chromium picolinate daily for 8-16 weeks might help reduce insulin resistance in HIV patients receiving antiretroviral therapy.
A type of depression called atypical depression. Early research shows that chromium picolinate might improve the remission rate in people with atypical depression. However, other evidence shows that taking chromium picolinate does not improve most symptoms of this type of depression.
Abnormal cholesterol levels caused by medications. Early research shows that taking 600 mcg of chromium daily for 2 months increases high-density lipoprotein (HDL or "good") cholesterol in men who take a class of drugs called beta-blockers.
Bipolar disorder. Early research shows that taking 600-800 mcg of chromium chloride daily for up to 2 years can decrease the frequency of severe mood disturbances in people with bipolar disorder that is resistant to treatment.
Long-term depression (dysthymia). There is some early evidence that chromium might improve how people with long-term, mild, depression respond to antidepressants. Taking chromium picolinate or chromium polynicotinate seems to improve mood in people who only partially respond to antidepressants.
Low blood sugar. Early research shows that taking chromium chloride daily for 3 months improves symptoms and increases blood sugar levels in people with low blood sugar. Other early research shows that taking chromium (Biochrome, Pharma-Nord) by mouth daily for 3 months improves symptoms, including chilliness, trembling, and disorientation, in people with low blood sugar.
Metabolic syndrome. Early evidence shows that taking a specific chromium product (Chromax, Nutrition21) twice daily for 12 weeks does not affect weight, waist circumferences, blood sugar, or cholesterol levels in people with metabolic syndrome.
Heart attack. Research shows that having low chromium levels in the toenail is associated with an increased risk for heart attack. However, toenail levels might not accurately measure chromium levels in the body. There is no reliable research showing that chromium supplements can prevent a heart attack.
An ovary disorder known as polycystic ovary syndrome (PCOS). Early research shows that taking chromium might improve insulin sensitivity and ovulation in women with PCOS. Doses of 1000 mcg per day seem to work best. Lower doses show conflicting results. Chromium doesn't seem to improve pregnancy rates or testosterone levels in women with PCOS.
Turner's syndrome (an inherited disease that often leads to diabetes). Early research shows chromium supplements might improve the processing of sugar and fat in people with Turner's syndrome.
High blood sugar related to steroid use.
More evidence is needed to rate the effectiveness of chromium for these uses.
Chromium is LIKELY SAFE for most adults when taken by mouth in medicinal amounts, short-term. Up to 1000 mcg per day of chromium has been used safely for up to 6 months.
Chromium is POSSIBLY SAFE for most adults when taken by mouth in medicinal amounts for longer periods of time. Chromium has been used safely in a small number of studies using doses of 200-1000 mcg daily for up to 2 years. Some people experience side effects such as skin irritation, headaches, dizziness, nausea, mood changes and impaired thinking, judgment, and coordination. High doses have been linked to more serious side effects including blood disorders, liver or kidney damage, and other problems. It is not known for sure if chromium is the actual cause of these side effects.
Children: Chromium is LIKELY SAFE when taken by mouth in amounts that do not exceed the "adequate intake" (AI) levels. For infants 0 to 6 months-old, the AI is 0.2 mcg daily; 7 to 12 months, 5.5 mcg. For children 1 to 3 years-old, the AI is 11 mcg; 4 to 8 years-old, 15 mcg. For boys 9 to 13 years-old, the AI is 25 mcg; 14 to 18 years-old, 35 mcg. For girls 9 to 13 years-old, the AI is 21 mcg; 14 to 18 years-old, 24 mcg. Taking chromium by mouth is POSSIBLY SAFE for children when used in amounts that exceed the AI levels. Pregnancy: Chromium is LIKELY SAFE to use during pregnancy when taken by mouth in amounts that do not exceed "adequate intake" (AI) levels. The AI for pregnant women 14 to 18 years-old is 29 mcg daily. For pregnant women 19 to 50 years-old, it is 30 mcg daily. Chromium is POSSIBLY SAFE to use during pregnancy in amounts higher than the AI levels. However, pregnant women should not take chromium supplements during pregnancy unless advised to do so by their healthcare provider.
Breast-feeding: Chromium is LIKELY SAFE to use while breast-feeding when taken by mouth in amounts that are equal to or less than "adequate intake" (AI) levels. The AI for breast-feeding women 14 to 18 years-old is 44 mcg daily. For breast-feeding women 19 to 50 years-old it is 45 mcg daily. There is not enough reliable information about the safety of taking higher amounts of chromium if you are breast-feeding. Stay on the safe side and avoid use.
Children: Chromium is LIKELY SAFE when taken by mouth in amounts that do not exceed the "adequate intake" (AI) levels. For infants 0 to 6 months-old, the AI is 0.2 mcg daily; 7 to 12 months, 5.5 mcg. For children 1 to 3 years-old, the AI is 11 mcg; 4 to 8 years-old, 15 mcg. For boys 9 to 13 years-old, the AI is 25 mcg. For girls 9 to 13 years-old, the AI is 21 mcg; 14 to 18 years-old, 24 mcg. Taking chromium by mouth is POSSIBLY SAFE when used in amounts that exceed the AI levels.
Kidney disease: There are at least three reports of kidney damage in patients who took chromium picolinate. Don't take chromium supplements, if you already have kidney disease.
Liver disease: There are at least three reports of liver damage in patients who took chromium picolinate. Don't take chromium supplements, if you already have liver disease.
Chromium might decrease blood sugar. Insulin is also used to decrease blood sugar. Taking chromium along with insulin might cause your blood sugar to be too low. Monitor your blood sugar closely. The dose of your insulin might need to be changed.
Taking chromium with levothyroxine (Synthroid) might decrease how much levothyroxine (Synthroid) that the body absorbs. This might make levothyroxine (Synthroid) less effective. To help avoid this interaction, levothyroxine (Synthroid) should be taken 30 minutes before or 3-4 hours after taking chromium.
NSAIDs are anti-inflammatory medications used for decreasing pain and swelling. NSAIDs might increase chromium levels in the body and increase the risk of adverse effects. Avoid taking chromium supplements and NSAIDs at the same time.<br /> Some NSAIDs include ibuprofen (Advil, Motrin, Nuprin, others), indomethacin (Indocin), naproxen (Aleve, Anaprox, Naprelan, Naprosyn), piroxicam (Feldene), aspirin, and others.
General: The safe and tolerable upper intake levels of chromium are not known. However, daily adequate intake (AI) levels for chromium have been established: men 14 to 50 years, 35 mcg; men 51 and older, 30 mcg; women 19 to 50 years, 25 mcg; women 51 and older, 20 mcg; pregnant women 14 to 18 years, 29 mcg; 19 to 50 years, 30 mcg; breast-feeding women 14 to 18 years, 44 mcg; 19 to 50 years, 45 mcg.
For diabetes: In people with type 2 diabetes, 200-1000 mcg of chromium taken daily in a single or divided doses has been used. Also, a specific combination product providing chromium 600 mcg plus biotin 2 mg daily (Diachrome by Nutrition 21) has also been used for up to 3 months. In addition, 1000 mcg of chromium (as chromium yeast) together with 1000 mg of vitamins C and 800 IU of vitamin E daily for 6 months has been used. In people with gestational diabetes, 4-8 mcg/kg of chromium picolinate daily for 8 weeks has been used. In people with high blood sugar due use of corticosteroid medication, 400 mcg of chromium once daily or 200 mcg three times daily has been used.
For high cholesterol: 50-250 mcg of chromium as chromium chloride or chromium picolinate, or brewer's yeast containing 15-48 mcg of chromium, has been used 5-7 days weekly for up to 16 months. 200 mcg of chromium polynicotinate along with 100 mg of grape seed extract, taken twice daily for 2 months, has been used. One to two capsules of a specific supplement (Colenon) containing 240 mg of chitosan, 55 mg of Garcinia cambogia extract, and 19 mg of chromium taken daily for 4 weeks has been used.
General: The safe and tolerable upper intake levels of chromium in children are not known. However, daily adequate intake (AI) levels for chromium have been established: Infants 0 to 6 months, 0.2 mcg; 7 to 12 months, 5.5 mcg; children 1 to 3 years, 11 mcg; 4 to 8 years, 15 mcg; boys 9 to 13 years, 25 mcg; boys 14-18 years. 35 mcg; girls 9 to 13 years, 21 mcg; 14 to 18 years, 24 mcg.
For high cholesterol: 400-600 mcg of chromium polynicotinate and 1000-1500 mg of glucomannan has been used twice daily for 8 weeks.
Aguilar, M. V., Jimenez-Jimenez, F. J., Molina, J. A., Meseguer, I., Mateos-Vega, C. J., Gonzalez-Munoz, M. J., de Bustos, F., Gomez-Escalonilla, C., Ort-Pareja, M., Zurdo, M., and Martinez-Para MC. Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's disease. J Neural Transm. 1998;105(10-12):1245-1251. View abstract.
Aharoni, A., Tesler, B., Paltieli, Y., Tal, J., Dori, Z., and Sharf, M. Hair chromium content of women with gestational diabetes compared with nondiabetic pregnant women. Am J Clin Nutr. 1992;55(1):104-107. View abstract.
Ali, A., Ma, Y., Reynolds, J., Wise, J. P., Sr., Inzucchi, S. E., and Katz, D. L. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus. Endocr.Pract. 2011;17(1):16-25. View abstract.
Almada A, Kreider R, Harmon K, and et al. Effects of ingesting a nutritional supplement containing chromium picolinate and boron on body composition during resistance-training [abstract]. FASEB J 1995;9:A1015.
Amann, B. L., Mergl, R., Vieta, E., Born, C., Hermisson, I., Seemueller, F., Dittmann, S., and Grunze, H. A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder. J Clin.Psychopharmacol. 2007;27(1):104-106. View abstract.
Amato, P., Morales, A. J., and Yen, S. S. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol.A Biol.Sci Med Sci 2000;55(5):M260-M263. View abstract.
Anderson R and Kozlovsky A. Chromium intake, absorption and excretion of subjects consuming self- selected diets. Am J.Clin.Nutr. 1985;41(6):1177-1183. View abstract.
Anderson R, Cheng N, Bryden N, and et al. Beneficial effects of chromium for people with type II diabetes [abstract]. Diabetes 1996;45(Suppl 2):124 A.
Anderson R, Polansky M, Bryden N, and et al. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism 1983;32(9):894-899. View abstract.
Anderson RA, Polansky MM, and Bryden NA. Acute effects on chromium, copper, zinc, and selected clinical variables in urine and serum of male runners. Biological Trace Element Research 1984;6:327-336.
Anderson RA, Polansky MM, Bryden NA, and et al. Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J.Nutr. 1983;113(2):276-281. View abstract.
Anderson RA. Effects of chromium on body composition and weight loss. Nutr.Rev. 1998;56(9):266-270. View abstract.
Anderson, R. A. Chromium in the prevention and control of diabetes. Diabetes Metab 2000;26(1):22-27. View abstract.
Anderson, R. A. Essentiality of chromium in humans. Sci.Total Environ. 10-1-1989;86(1-2):75-81. View abstract.
Anderson, R. A. Nutritional factors influencing the glucose/insulin system: chromium. J Am.Coll.Nutr. 1997;16(5):404-410. View abstract.
Anderson, R. A. Trace elements and cardiovascular diseases. Acta Pharmacol Toxicol.(Copenh) 1986;59 Suppl 7:317-324. View abstract.
Anderson, R. A., Bryden, N. A., and Polansky, M. M. Serum chromium of human subjects: effects of chromium supplementation and glucose. Am.J Clin Nutr. 1985;41(3):571-577. View abstract.
Anderson, R. A., Bryden, N. A., Polansky, M. M., and Deuster, P. A. Exercise effects on chromium excretion of trained and untrained men consuming a constant diet. J Appl.Physiol 1988;64(1):249-252. View abstract.
Anderson, R. A., Polansky, M. M., Bryden, N. A., Roginski, E. E., Patterson, K. Y., Veillon, C., and Glinsmann, W. Urinary chromium excretion of human subjects: effects of chromium supplementation and glucose loading. Am.J Clin Nutr. 1982;36(6):1184-1193. View abstract.
Anderson, R. A., Roussel, A. M., Zouari, N., Mahjoub, S., Matheau, J. M., and Kerkeni, A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J.Am.Coll.Nutr. 2001;20(3):212-218. View abstract.
Anton, S. D., Morrison, C. D., Cefalu, W. T., Martin, C. K., Coulon, S., Geiselman, P., Han, H., White, C. L., and Williamson, D. A. Effects of chromium picolinate on food intake and satiety. Diabetes Technol.Ther. 2008;10(5):405-412. View abstract.
Bagdon RE and Hazen RE. Skin permeation and cutaneous hypersensitivity as a basis for making risk assessments of chromium as a soil contaminant. Environ.Health Perspect. 1991;92:111-119. View abstract.
Bahadori, B., Wallner, S., Schneider, H., Wascher, T. C., and Toplak, H. [Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet]. Acta Med Austriaca 1997;24(5):185-187. View abstract.
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., and Pittas, A. G. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 2007;30(8):2154-2163. View abstract.
Bartlett, H. E. and Eperjesi, F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. 2008;28(6):503-523. View abstract.
Bharmal, S. V., Moyes, V., Ahmed, S., and Grossman, A. Hypoglycaemia: possible mediation by chromium salt medication. Hormones.(Athens.) 2010;9(2):181-183. View abstract.
Bourn DM, Gibson RS, Martinez OB, and et al. The effect of chromium supplementation on serum lipid levels in a selected sample of Canadian postmenopausal women. Biological Trace Element Research 1986;9:197-205.
Boyd SG, Boone BE, Smith AR, and et al. Combined dietary chromium picolinate supplementation and an exercise program leads to a reduction of serum cholesterol and insulin in college-aged subjects. J Nutr Biochem 1998;9:471-475.
Bulbulian R, Pringle DD, and Liddy MS. Chromium picolinate supplementation in male and female swimmers [abstract]. Medicine and Science in Sports and Exercise 1996;28(5 Supplement):s111.
Bunner S and McGinnis R. Chromium-induced hypoglycemia. Psychosomatics 1998;39(3):298-299. View abstract.
Caglieri, A., Goldoni, M., De, Palma G., Mozzoni, P., Gemma, S., Vichi, S., Testai, E., Panico, F., Corradi, M., Tagliaferri, S., and Costa, L. G. Exposure to low levels of hexavalent chromium: target doses and comparative effects on two human pulmonary cell lines. Acta Biomed. 2008;79 Suppl 1:104-115. View abstract.
Campbell W, Joseph L, and Davey S. Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men. J.Appl.Physiol 1999;86(1):29-39. View abstract.
Cefalu WT, Bell-Farrow AD, Wang ZQ, and et al. The effect of chromium supplementation on carbohydrate metabolism and body fat distribution [abstract]. Diabetes 1997;46(suppl 1):55A.
Cefalu, W. T. and Hu, F. B. Role of chromium in human health and in diabetes. Diabetes Care 2004;27(11):2741-2751. View abstract.
Cefalu, WT. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exptl Med 1999;12:71-83.
Chen, G., Liu, P., Pattar, G. R., Tackett, L., Bhonagiri, P., Strawbridge, A. B., and Elmendorf, J. S. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol.Endocrinol. 2006;20(4):857-870. View abstract.
Cheng N. Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium. J Trace Elem Exptl Med 1999;12:71-83.
Chhabra, D., Oda, K., Jagannath, P., Utsunomiya, H., Takekoshi, S., and Nimura, Y. Chronic heavy metal exposure and gallbladder cancer risk in India, a comparative study with Japan. Asian Pac.J.Cancer Prev. 2012;13(1):187-190. View abstract.
Clancy, S. P., Clarkson, P. M., DeCheke, M. E., Nosaka, K., Freedson, P. S., Cunningham, J. J., and Valentine, B. Effects of chromium picolinate supplementation on body composition, strength, and urinary chromium loss in football players. Int.J.Sport Nutr. 1994;4(2):142-153. View abstract.
Clarkson, P. M. Effects of exercise on chromium levels. Is supplementation required? Sports Med 1997;23(6):341-349. View abstract.
Clarkson, P. M. Micronutrients and exercise: anti-oxidants and minerals. J Sports Sci 1995;13 Spec No:S11-S24. View abstract.
Clausen J. Chromium induced clinical improvement in symptomatic hypoglycemia. Biol.Trace Elem.Res. 1988;17:229-236. View abstract.
Cowart VS. Dietary supplements: alternatives to anabolic steroids? The Physician and Sportsmedicine 1992;20(3):189-193, 196, 198.
Crawford, V., Scheckenbach, R., and Preuss, H. G. Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. Diabetes Obes.Metab 1999;1(6):331-337. View abstract.
Cruz, M. J., Costa, R., Marquilles, E., Morell, F., and Munoz, X. [Occupational asthma caused by chromium and nickel]. Arch.Bronconeumol. 2006;42(6):302-306. View abstract.
Davi, G., Santilli, F., and Patrono, C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc.Ther 2010;28(4):216-226. View abstract.
Diaz, M. L., Watkins, B. A., Li, Y., Anderson, R. A., and Campbell, W. W. Chromium picolinate and conjugated linoleic acid do not synergistically influence diet- and exercise-induced changes in body composition and health indexes in overweight women. J.Nutr.Biochem. 2008;19(1):61-68. View abstract.
Docherty, J. P., Sack, D. A., Roffman, M., Finch, M., and Komorowski, J. R. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiatr.Pract. 2005;11(5):302-314. View abstract.
Drake, T. C., Rudser, K. D., Seaquist, E. R., and Saeed, A. Chromium infusion in hospitalized patients with severe insulin resistance: a retrospective analysis. Endocr.Pract. 2012;18(3):394-398. View abstract.
Evans G and Pouchnik D. Composition and biological activity of chromium-pyridine carboxylate complexes. J.Inorg.Biochem. 2-15-1993;49(3):177-187. View abstract.
Evans, GW. The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 1989;11(2):163-180.
Feiner, J. J., McNurlan, M. A., Ferris, R. E., Mynarcik, D. C., and Gelato, M. C. Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study. Diabetes Obes.Metab 2008;10(2):151-158. View abstract.
Gao, W., Liu, L., Liu, Z. Y., Li, X. D., and Li, C. Interstitial injection of (32)P-chromic phosphate during lung cancer resection to treat occult lymphatic metastasis. Nucl.Med.Commun. 2009;30(6):420-426. View abstract.
Gatto, N. M., Kelsh, M. A., Mai, D. H., Suh, M., and Proctor, D. M. Occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract: a meta-analysis. Cancer Epidemiol. 2010;34(4):388-399. View abstract.
Ghosh, D., Bhattacharya, B., Mukherjee, B., Manna, B., Sinha, M., Chowdhury, J., and Chowdhury, S. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J.Nutr.Biochem. 2002;13(11):690-697. View abstract.
Gibb, H. J., Lees, P. S., Pinsky, P. F., and Rooney, B. C. Clinical findings of irritation among chromium chemical production workers. Am J Ind.Med 2000;38(2):127-131. View abstract.
Gibb, H. J., Lees, P. S., Pinsky, P. F., and Rooney, B. C. Lung cancer among workers in chromium chemical production. Am J Ind.Med 2000;38(2):115-126. View abstract.
Girola M, De Bernardi M, and Contos S, et al. Dose effect in lipid-lowering activity of a new dietary integrator (chitosan, Garcinia cambogia extract and chrome). Acta Toxicol Ther 1996;17(1):25-40.
Glinsmann, W. H. and Mertz, W. Effect of trivalent chromium on glucose tolerance. Metabolism 1966;15(6):510-520. View abstract.
Granchi, D., Verri, E., Ciapetti, G., Savarino, L., Cenni, E., Gori, A., and Pizzoferrato, A. Effects of chromium extract on cytokine release by mononuclear cells. Biomaterials 1998;19(1-3):283-291. View abstract.
Hambidge, K. M., Franklin, M. L., and Jacobs, M. A. Changes in hair chromium concentrations with increasing distances from hair roots. Am J Clin Nutr. 1972;25(4):380-383. View abstract.
Hambidge, K. M., Franklin, M. L., and Jacobs, M. A. Hair chromium concentration: effects of sample washing and external environment. Am J Clin Nutr. 1972;25(4):384-389. View abstract.
Hambidge, K. M., Rodgerson, D. O., and O'Brien, D. Concentration of chromium in the hair of normal children and children with juvenile diabetes mellitus. Diabetes 1968;17(8):517-519. View abstract.
Hannu, T., Piipari, R., Kasurinen, H., Keskinen, H., Tuppurainen, M., and Tuomi, T. Occupational asthma due to manual metal-arc welding of special stainless steels. Eur.Respir.J 2005;26(4):736-739. View abstract.
Hasten, D. L., Rome, E. P., Franks, B. D., and Hegsted, M. Effects of chromium picolinate on beginning weight training students. Int.J.Sport Nutr. 1992;2(4):343-350. View abstract.
Hermann J, Arquitt A, and Stoecker B. Effects of chromium supplementation on plasma lipids, apolipoproteins, and glucose in elderly subjects. Nutrition Research 1994;14(5):671-674.
Hisatomi, K., Ishii, H., Hashiguchi, K., Seki, M., Ide, M., Sugiyama, K., Ishimoto, H., Nakayama, S., Mukae, H., and Kohno, S. Interstitial pneumonia caused by inhalation of fumes of nickel and chrome. Respirology. 2006;11(6):814-817. View abstract.
Hockney, R. A., Montgomery, P., Williams, C., Geddes, J. R., and Cowen, P. J. Lack of effect of chromium supplementation on mental state and body weight in people with schizophrenia. J Clin.Psychopharmacol. 2006;26(5):544-545. View abstract.
Huszonek, J. Over-the-counter chromium picolinate. Am J Psychiatry 1993;150(10):1560-1561. View abstract.
Iqbal, N., Cardillo, S., Volger, S., Bloedon, L. T., Anderson, R. A., Boston, R., and Szapary, P. O. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr.Relat Disord. 2009;7(2):143-150. View abstract.
Jain, S. K., Kahlon, G., Morehead, L., Dhawan, R., Lieblong, B., Stapleton, T., Caldito, G., Hoeldtke, R., Levine, S. N., and Bass, P. F., III. Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-alpha, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study. Mol.Nutr.Food Res. 2012;56(8):1333-1341. View abstract.
Jeejeebhoy, K. N., Chu, R. C., Marliss, E. B., Greenberg, G. R., and Bruce-Robertson, A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 1977;30(4):531-538. View abstract.
Joseph, L. J., Farrell, P. A., Davey, S. L., Evans, W. J., and Campbell, W. W. Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women. Metabolism 1999;48(5):546-553. View abstract.
Jovanovic L, Gutierrez M, and Peterson CM. Chromium supplementation for women with gestational diabetes mellitus. J Trace Elem Exp Med 1999;12(2):91-97.
Jovanovic-Peterson L, Gutierrez M, and Peterson CM. Chromium supplementation for gestational diabetic women (GDM) improves glucose tolerance and decreases hyperinsulinemia [abstract]. Diabetes 1996;45(Suppl 2):337A.
Kaats GR, Blum K, Fisher JA, and et al. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Current Therapeutic Research 1996;57(10):747-756.
Kaats GR, Blum K, Pullin D, and et al. A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Current Therapeutic Research 1998;59(6):379-388.
Kaats GR. The short term therapeutic efficacy of treating obesity with a plan of improved nutrition and moderate calorie restriction. Curr Ther Res 1992;51:261-274.
Kato, I., Vogelman, J. H., Dilman, V., Karkoszka, J., Frenkel, K., Durr, N. P., Orentreich, N., and Toniolo, P. Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. Eur.J Epidemiol. 1998;14(6):621-626. View abstract.
Kelly GS. Sports nutrition: A review of selected nutritional supplements for bodybuilders and strength athletes. Alt Med Rev 1997;2(3):184-201.
Kelly, G. S. Insulin resistance: lifestyle and nutritional interventions. Altern.Med Rev 2000;5(2):109-132. View abstract.
Keszthelyi, Z., Past, T., Koltai, K., Szabo, L., and Mozsik, G. [Chromium (III)-ion enhances the utilization of glucose in type-2 diabetes mellitus]. Orv.Hetil. 10-19-2003;144(42):2073-2076. View abstract.
Kim, C. W., Kim, B. T., Park, K. H., Kim, K. M., Lee, D. J., Yang, S. W., and Joo, N. S. Effects of short-term chromium supplementation on insulin sensitivity and body composition in overweight children: randomized, double-blind, placebo-controlled study. J.Nutr.Biochem. 2011;22(11):1030-1034. View abstract.
Kleefstra, N., Houweling, S. T., Bakker, S. J., Verhoeven, S., Gans, R. O., Meyboom-de Jong, B., and Bilo, H. J. Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2007;30(5):1092-1096. View abstract.
Kozlovsky, A. S., Moser, P. B., Reiser, S., and Anderson, R. A. Effects of diets high in simple sugars on urinary chromium losses. Metabolism 1986;35(6):515-518. View abstract.
Krikorian, R., Eliassen, J. C., Boespflug, E. L., Nash, T. A., and Shidler, M. D. Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr.Neurosci. 2010;13(3):116-122. View abstract.
Krol, E., Krejpcio, Z., Byks, H., Bogdanski, P., and Pupek-Musialik, D. Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol.Trace Elem.Res. 2011;143(2):726-737. View abstract.
Lai, M. H. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus. J Clin Biochem.Nutr 2008;43(3):191-198. View abstract.
Lane B. Diet and the glaucomas [abstract]. J Am Coll Nutr. 1991;10:536.
Lees, P. S. Chromium and disease: review of epidemiologic studies with particular reference to etiologic information provided by measures of exposure. Environ Health Perspect. 1991;92:93-104. View abstract.
Lefavi RG, Wilson GD, Keith RE, and et al. Lipid-lowering effect of a dietary chromium (III) - nicotinic acid complex in male athletes. Nutrition Research 1993;13:239-249.
Leroyer, C., Dewitte, J. D., Bassanets, A., Boutoux, M., Daniel, C., and Clavier, J. Occupational asthma due to chromium. Respiration 1998;65(5):403-405. View abstract.
Levine, R. A., Streeten, D. H., and Doisy, R. J. Effects of oral chromium supplementation on the glucose tolerance of elderly human subjects. Metabolism 1968;17(2):114-125. View abstract.
Littlefield, D. Chromium decreases blood glucose in a patient with diabetes. J Am Diet Assoc 1994;94(12):1368. View abstract.
Livolsi, J. M., Adams, G. M., and Laguna, P. L. The effect of chromium picolinate on muscular strength and body composition in women athletes. J.Strength.Cond.Res. 2001;15(2):161-166. View abstract.
Lucidi, R. S., Thyer, A. C., Easton, C. A., Holden, A. E., Schenken, R. S., and Brzyski, R. G. Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Fertil.Steril. 2005;84(6):1755-1757. View abstract.
Lukaski, H. C. Chromium as a supplement. Annu.Rev.Nutr. 1999;19:279-302. View abstract.
Lukaski, H. C. Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr. 2000;72(2 Suppl):585S-593S. View abstract.
Lukaski, H. C., Siders, W. A., and Penland, J. G. Chromium picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition 2007;23(3):187-195. View abstract.
Martin, W. R. and Fuller, R. E. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18(4):860-862. View abstract.
Martinez OB, MacDonald AC, Gibson RS, and et al. Dietary chromium and effect of chromium suppelmentation on glucose tolerance of elderly canadian women. Nutrition Research 1985;5:609-620.
McArdle WD and Moore BJ. Chromium shows little proof as weight loss supplement. Altern Med Alert 1998;1:9-10.
McCarty, M. F. Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density. Med Hypotheses 1995;45(3):241-246. View abstract.
McCarty, M. F. Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control. Med Hypotheses 1996;46(2):77-80. View abstract.
McCarty, M. F. Complementary measures for promoting insulin sensitivity in skeletal muscle. Med Hypotheses 1998;51(6):451-464. View abstract.
McCarty, M. F. Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy-- preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline. Med Hypotheses 1998;50(5):435-449. View abstract.
McCarty, M. F. Over-the-counter chromium and renal failure. Ann.Intern.Med 10-15-1997;127(8 Pt 1):654-655. View abstract.
McLeod, M. N. and Golden, R. N. Chromium treatment of depression. Int J Neuropsychopharmacol 2000;3(4):311-314. View abstract.
Mertz, W. Chromium in human nutrition: a review. J Nutr 1993;123(4):626-633. View abstract.
Mertz, W. Confirmation: chromium levels in serum, hair, and sweat decline with age. Nutr Rev. 1997;55(10):373-375. View abstract.
Morris BW. Chromium action and glucose homeostasis. J Trace Elem Exptl Med 1999;12(2):61-70.
Morris, B. W., MacNeil, S., Hardisty, C. A., Heller, S., Burgin, C., and Gray, T. A. Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol 1999;13(1-2):57-61. View abstract.
Mossop, R. T. Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics. Cent.Afr.J Med 1983;29(4):80-82. View abstract.
Nath R, Minocha J, Lyall V, and et al. Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium-51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels. In: Shapcott D and Hubert J. Chromium in Nutrition and Metabolism. Amsterdam: Elsevier/North-Holland Biomedical Press;1979.
Newman, H. A., Leighton, R. F., Lanese, R. R., and Freedland, N. A. Serum chromium and angiographically determined coronary artery disease. Clin Chem. 1978;24(4):541-544. View abstract.
Noda, S., Asano, Y., and Sato, S. Lichen planus in a patient with long-term exposure to chrome. Eur.J.Dermatol. 2011;21(3):417-418. View abstract.
O'Flaherty, E. J., Kerger, B. D., Hays, S. M., and Paustenbach, D. J. A physiologically based model for the ingestion of chromium(III) and chromium(VI) by humans. Toxicol.Sci 2001;60(2):196-213. View abstract.
O'Mathuna DP. Chromium supplementation for weight loss. Alternative Medicine Alert 2001;4(4):37-48.
Offenbacher E, Miou J Moussas A Pi-Sunyer F. Chromium (Cr) intake and urinary Cr excretion in young adults. Fed Proc 1985;44(1848):8393.
Offenbacher, E. G. and Pi-Sunyer, F. X. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 1980;29(11):919-925. View abstract.
Offenbacher, E. G. and Pi-Sunyer, F. X. Chromium in human nutrition. Annu.Rev.Nutr. 1988;8:543-563. View abstract.
Offenbacher, E. G., Rinko, C. J., and Pi-Sunyer, F. X. The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjects. Am J Clin Nutr 1985;42(3):454-461. View abstract.
Parsons, A., Ingram, J., Inglis, J., Aveyard, P., Johnstone, E., Brown, K., Franklin, M., and Bermudez, I. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation. Drug Alcohol Depend. 6-1-2009;102(1-3):116-122. View abstract.
Pasman, W. J., Westerterp-Plantenga, M. S., and Saris, W. H. The effectiveness of long-term supplementation of carbohydrate, chromium, fibre and caffeine on weight maintenance. Int J Obes.Relat Metab Disord. 1997;21(12):1143-1151. View abstract.
Pei, D., Hsieh, C. H., Hung, Y. J., Li, J. C., Lee, C. H., and Kuo, S. W. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 2006;55(7):923-927. View abstract.
Pekarek, R. S., Hauer, E. C., Rayfield, E. J., Wannemacher, R. W., and Beisel, W. R. Relationship between serum chromium concentrations and glucose utilization in normal and infected subjects. Diabetes 1975;24(4):350-353. View abstract.
Pittler, M. H. and Ernst, E. Complementary therapies for reducing body weight: a systematic review. Int.J.Obes.(Lond) 2005;29(9):1030-1038. View abstract.
Pohl, M., Mayr, P., Mertl-Roetzer, M., Lauster, F., Haslbeck, M., Hipper, B., Steube, D., Tietjen, M., Eriksen, J., and Rahlfs, V. W. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. JPEN J.Parenter.Enteral Nutr. 2009;33(1):37-49. View abstract.
Prasad, K. N., Cole, W. C., and Kumar, B. Multiple antioxidants in the prevention and treatment of Parkinson's disease. J Am Coll Nutr. 1999;18(5):413-423. View abstract.
Press, R. I., Geller, J., and Evans, G. W. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 1990;152(1):41-45. View abstract.
Preuss, H. G., Garis, R. I., Bramble, J. D., Bagchi, D., Bagchi, M., Rao, C. V., and Satyanarayana, S. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control. Int.J Clin.Pharmacol.Res. 2005;25(3):133-144. View abstract.
Proctor, D. M., Fredrick, M. M., Scott, P. K., Paustenbach, D. J., and Finley, B. L. The prevalence of chromium allergy in the United States and its implications for setting soil cleanup: a cost-effectiveness case study. Regul.Toxicol Pharmacol 1998;28(1):27-37. View abstract.
Quarles, C. D., Jr., Brumaghim, J. L., and Marcus, R. K. Instrumental comparison of the determination of Cr(3)+ uptake by human transferrin. Metallomics. 2010;2(12):792-799. View abstract.
Rabinowitz MB, Gonick HC, Levine SR, and et al. Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Biol Trace Elem Res 1983;5:449-466.
Racek, J., Trefil, L., Rajdl, D., Mudrova, V., Hunter, D., and Senft, V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol.Trace Elem.Res. 2006;109(3):215-230. View abstract.
Ravina A, Slezak L, Mirsky N, and et al. Control of steroid-induced diabetes with supplemental chromium. J Trace Elem Exper Med 1999;12(4):375-378.
Ravina A, Slezak L, Rubal A, and et al. Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elem Exper Med 1995;8:183-190.
Riales, R. and Albrink, M. J. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr. 1981;34(12):2670-2678. View abstract.
Romero, R. A., Salgado, O., Rodriguez-Iturbe, B., and Tahan, J. E. Blood levels of chromium in diabetic and nondiabetic hemodialysis patients. Transplant.Proc 1996;28(6):3382-3384. View abstract.
Rothacker DQ, Waitman BE. Effectiveness of a Garcinia cambogia and natural caffeine combination in weight loss - a double-blind, placebo controlled pilot study. Int J Obes Relat Metab Disord 1997;21(53):1.
Saper, R. B., Eisenberg, D. M., and Phillips, R. S. Common dietary supplements for weight loss. Am.Fam.Physician 11-1-2004;70(9):1731-1738. View abstract.
Schroeder, H. A. The role of chromium in mammalian nutrition. Am J Clin Nutr 1968;21(3):230-244. View abstract.
Shapiro, K. and Gong, W. C. Natural products used for diabetes. J Am Pharm Assoc (Wash.) 2002;42(2):217-226. View abstract.
Sharma, S., Agrawal, R. P., Choudhary, M., Jain, S., Goyal, S., and Agarwal, V. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J.Trace Elem.Med.Biol. 2011;25(3):149-153. View abstract.
Sherman, L., Glennon, J. A., Brech, W. J., Klomberg, G. H., and Gordon, E. S. Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism 1968;17(5):439-442. View abstract.
Shumilla, J. A., Broderick, R. J., Wang, Y., and Barchowsky, A. Chromium(VI) inhibits the transcriptional activity of nuclear factor- kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J Biol Chem. 12-17-1999;274(51):36207-36212. View abstract.
Simonoff M, Llabador Y, Hamon C, and et al. Low plasma chromium in patients with coronary artery and heart diseases. Biological Trace Element Research 1984;6:431-439.
Sodergren, M. H., Jethwa, P., Kumar, S., Duncan, H. D., Johns, T., and Pearce, C. B. Immunonutrition in patients undergoing major upper gastrointestinal surgery: a prospective double-blind randomised controlled study. Scand.J.Surg. 2010;99(3):153-161. View abstract.
Stoecker BJ. Chromium. In: Shils M and et al. Nutrition in Health and Disease. Baltimore: Williams & Wilkins;1999.
Stupar, J., Vrtovec, M., Kocijancic, A., and Gantar, A. Chromium status of tannery workers in relation to metabolic disorders. J Appl.Toxicol. 1999;19(6):437-446. View abstract.
Thomas, V. L. and Gropper, S. S. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol.Trace Elem.Res. 1996;55(3):297-305. View abstract.
Trow, L. G., Lewis, J., Greenwood, R. H., Sampson, M. J., Self, K. A., Crews, H. M., and Fairweather-Tait, S. J. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes. Int.J Vitam.Nutr.Res 2000;70(1):14-18. View abstract.
Unisa, S., Jagannath, P., Dhir, V., Khandelwal, C., Sarangi, L., and Roy, T. K. Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford) 2011;13(2):117-125. View abstract.
Uusitupa MI, Kumpulainen JT, Voutilainen E, and et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. The American Journal of Clinical Nutrition 1983;38:404-410.
Uusitupa MI, Mykkänen L, Siitonen O, and et al. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. British Journal of Nutrition 1992;68:209-216.
Via, M., Scurlock, C., Raikhelkar, J., Di, Luozzo G., and Mechanick, J. I. Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr.Clin.Pract. 2008;23(3):325-328. View abstract.
Vinson JA and Bose P. The effect of a high chromium yeast on the blood glucose control and blood lipids of normal and diabetic human subjects. Nutrition Reports International 1984;30(4):911-918.
Vrtovec, M., Vrtovec, B., Briski, A., Kocijancic, A., Anderson, R. A., and Radovancevic, B. Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus. Am.Heart J. 2005;149(4):632-636. View abstract.
Walker, L. S., Bemben, M. G., Bemben, D. A., and Knehans, A. W. Chromium picolinate effects on body composition and muscular performance in wrestlers. Med.Sci.Sports Exerc. 1998;30(12):1730-1737. View abstract.
Wang MW, Fox EA, Stoecker BJ, and et al. Serum cholesterol of adults supplemented with brewer's yeast or chromium chloride. Nutrition Research 1989;9:989-998.
Wang, Z. Q., Qin, J., Martin, J., Zhang, X. H., Sereda, O., Anderson, R. A., Pinsonat, P., and Cefalu, W. T. Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. Metabolism 2007;56(12):1652-1655. View abstract.
Williams, M. H. Nutritional ergogenics in athletics. J Sports Sci 1995;13 Spec No:S63-S74. View abstract.
Wilson BE and Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res.Clin.Pract. 1995;28(3):179-184. View abstract.
Wrobel K, Garay-Sevilla ME, Malacara JM, and et al. Effect of chromium on glucose tolerance, serum cholesterol and triglyceride levels in occupational exposure to trivalent species in type 2 diabetic patients and in control subjects. Trace Elements & Electrolytes 1999;16(4):199-205.
Xiang, J., Sun, Z., and Huan, J. N. Intensive chromic acid burns and acute chromium poisoning with acute renal failure. Chin Med.J.(Engl.) 7-5-2011;124(13):2071-2073. View abstract.
Young P, Turiansky G, Bonner M, and et al. Acute generalized exanthematous pustulosis induced by chromium picolinate. J.Am Acad.Dermatol. 1999;41(5 Pt 2):820-823. View abstract.
Zook, J. E., Wurtz, D. L., Cummings, J. E., and Cardenes, H. R. Intra-articular chromic phosphate ((3)(2)P) in the treatment of diffuse pigmented villonodular synovitis. Brachytherapy. 2011;10(3):190-194. View abstract.
Abdollahi M, Farshchi A, Nikfar S, Seyedifar M. Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. J Pharm Pharm Sci 2013;16(1):99-114. View abstract.
Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin dependent diabetes. Metabolism 1992;41:768-71. View abstract.
Adams, J. B., Baral, M., Geis, E., Mitchell, J., Ingram, J., Hensley, A., Zappia, I., Newmark, S., Gehn, E., Rubin, R. A., Mitchell, K., Bradstreet, J., and El-Dahr, J. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results. BMC.Clin.Pharmacol. 2009;9:16. View abstract.
Althius MD, Jordon NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 2002;76:148-55. View abstract.
Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997;46:1786-91. View abstract.
Anderson RA, Polansky MM, Bryden NA, et al. Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism 1987;36:351-5. View abstract.
Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr 1998;17:548-55. View abstract.
Ashoush S, Abou-Gamrah A, Bayoumy H, Othman N. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial. J Obstet Gynaecol Res. 2016;42(3):279-85. View abstract.
Attenburrow MJ, Odontiadis J, Murray BJ, et al. Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology (Berl) 2002;159:432-6. View abstract.
Bailey CH. Improved meta-analytic methods show no effect of chromium supplements on fasting glucose. Biol Trace Elem Res 2014;157(1):1-8. View abstract.
Berardi R, Pellei C, Valeri G, Pistelli M, Onofri A, Morgese F, Caramanti M, Mirza RM, Santoni M, De Lisa M, Savini A, Ballatore Z, Giuseppetti GM, Cascinu S. Chromium exposure and germinal embryonal carcinoma: first two cases and review of the literature. J Toxicol Environ Health A 2015;78(1):1-6. View abstract.
Blasiak J, Kowalik J. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat Res 2000;469:135-45. View abstract.
Brownley KA, Von Holle A, Hamer RM, La Via M, Bulik CM. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study. J Psychosom Res 2013;75(1):36-42. View abstract.
Campbell WW, Beard JL, Joseph LJ, et al. Chromium picolinate supplementation and resistive training by older men: effects on iron status and hematologic indexes. Am J Clin Nutr 1997;66:944-9. View abstract.
Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31. View abstract.
Cheng HH, Lai MH, Hou WC, Huang CL. Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem 2004;52:1385-9. View abstract.
Davidson JR, Abraham K, Connor KM, McLeod MN. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261-4.. View abstract.
Davies S, Howard JM, Hunnisett A, et al. Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients - implications for the prevention of cardiovascular disease and type II diabetes. Metabolism 1997;46:469-73. View abstract.
Davis ML, Seaborn CD, and Stoecker BJ. Effects of over-the-counter drugs on chromium retention and urinary excretion in rats. Nutrition Research 1995;15(2):201-210.
De Marchi S, Cecchin E, De Marchi SU. Systemic allergic dermatitis resulting from oral administration of chromium with a food supplement. Contact Dermatitis 2014;70(2):123-5. View abstract.
Food and Nutrition Board, Institute of Medicine. Prototype monograph on chromium picolinate. Washington, DC: National Academy Press, 2005. Available at: http://www.iom.edu/CMS/3788/19554.aspx.
Food Standards Agency. Medicines and Healthcare products Regulatory Agency (MHRA). Expert Group on Vitamins and Minerals. Available at: http://cot.food.gov.uk/sites/default/files/vitmin2003.pdf.
Fowler JF Jr. Systemic contact dermatitis caused by oral chromium picolinate. Cutis 2000;65:116. View abstract.
Fox GN, Sabovic Z. Chromium picolinate supplementation for diabetes mellitus. J Fam Pract 1998;46:83-6. View abstract.
Frauchiger MT, Wenk C, Colombani PC. Effects of acute chromium supplementation on postprandial metabolism in healthy young men. J Am Coll Nutr 2004;23:351-7. View abstract.
Freund H, Atamian S, Fischer JE. Chromium deficiency during total parenteral nutrition. JAMA 1979;241:496-8. View abstract.
Grant KE, Chandler RM, Castle AL, Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports Exerc 1997;29:992-8. View abstract.
Guallar E, Jimenez FJ, van 't Veer P, et al. Low toenail chromium concentration and increased risk of nonfatal myocardial infarction. Am J Epidemiol 2005;162:157-64. View abstract.
Guimarães MM, Carvalho AC, Silva MS. Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: Double blind, randomized clinical trial: Chromium, glucose homeostasis and anthropometry. J Trace Elem Med Biol. 2016;36:65-72. View abstract.
Guimarães MM, Martins Silva Carvalho AC, Silva MS. Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes. J Am Coll Nutr 2013;32(4):243-50. View abstract.
Gunton JE, Cheung NW, Hitchman R, et al. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 2005;28:712-3. View abstract.
Hahn CJ, Evans GW. Absorption of trace metals in the zinc-deficient rat. Am J Physiol 1975;228:1020-3. View abstract.
Hedberg YS, Gumulka M, Lind ML, Matura M, Lidén C. Severe occupational chromium allergy despite cement legislation. Contact Dermatitis. 2014;70(5):321-3. View abstract.
Jamilian M, Asemi Z. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Nutr Metab. 2015;67(1):42-8. View abstract.
John-Kalarickal J, Pearlman G, Carlson HE. New medications which decrease levothyroxine absorption. Thyroid 2007;17:763-5. View abstract.
Kaats GR, Blum K, Fisher JA, Adelman JA. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Curr Ther Res 1996;57:747-56.
Kaats GR, Blum K, Pullin D, et al. A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res 1998;59:379-88.
Kleefstra N, Houweling ST, Jansman FG, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2006;29:521-5. View abstract.
Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994;17:1449-52. View abstract.
Liu VJ, Abernathy RP. Chromium and insulin in young subjects with normal glucose tolerance. Am J Clin Nutr 1982;35:661-7. View abstract.
Lukaski HC, Bolonchuk WW, Siders WA, Milne DB. Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nutr 1996;63:954-65. View abstract.
Lydic ML, McNurlan M, Bembo S, et al. Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome. Fertil Steril 2006;86:243-6. View abstract.
Maher TJ. Chromium and other minerals in diabetes mellitus. US Pharm 1999;24:66-76.
Martin J, Wang ZQ, Zhang XH, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006;29:1826-32. View abstract.
Martino F, Puddu PE, Pannarale G, Colantoni C, Martino E, Niglio T, Zanoni C, Barillà F. Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan. Atherosclerosis. 2013;228(1):198-202. View abstract.
McCarty MF. Chromium supplementation and iron metabolism [letter]. Am J Clin Nutr 1997;65:890-2. View abstract.
McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients. J Clin Psych 1999;60:237-40. View abstract.
Mertz W. Interaction of chromium with insulin: a progress report. Nutr Rev 1998;56:174-7. View abstract.
Mohamedshah FY, Moser-Veillon PB, Yamini S, et al. Distribution of a stable isotope of chromium (53Cr) in serum, urine, and breast milk in lactating women. Am J Clin Nutr 1998;67:1250-5. View abstract.
Morris BW, Kemp GJ, Hardisty CA. Plasma chromium and chromium excretion in diabetes. Clin Chem 1985;31:334-5. View abstract.
Mouser JF, Hak EB, Helms RA, et al. Chromium and zinc concentrations in pediatric patients receiving long-term parenteral nutrition. Am J Health Syst Pharm 1999;56:1950-6. View abstract.
Mulyani I, Levina A, Lay PA. Biomimetic oxidation of chromium(III): does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)? Angew Chem Int Ed Engl 2004;43:4504-7. View abstract.
Onakpoya I, Posadzki P, Ernst E. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obes Rev 2013;14(6):496-507. View abstract.
Paiva AN, Lima JG, Medeiros AC, et al. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study. J Trace Elem Med Biol. 2015;32:66-72. View abstract.
Pittler MH, Stevinson C, Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int J Obes Relat Metab Disord 2003;27:522-9. View abstract.
Qualified Health Claims: Letter of Enforcement Discretion -Chromium Picolinate and Insulin Resistance (Docket No. 2004Q-0144).CFSAN/Office of Nutritional Products, Labeling, and Dietary Supplements August 25, 2005. Available at: http://www.cfsan.fda.gov/~dms/qhccr.html.
Rabinovitz H, Friedensohn A, Leibovitz A, et al. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int J Vitam Nutr Res 2004;74:178-82. View abstract.
Rajpathak S, Rimm EB, Li T, et al. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 2004;27:2211-6. View abstract.
Ravina A, Slezak L, Mirsky N, et al. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet Med 1999;16:164-7. View abstract.
Roeback JR Jr, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial. Ann Intern Med 1991;115:917-24. View abstract.
Rubin MA, Miller JP, Ryan AS, et al. Acute and chronic resistive exercise increase urinary chromium excretion in men as measured with an enriched chromium stable isotope. J Nutr 1998;128:73-78. View abstract.
Seaborn CD and Stoecker BJ. Effects of antacid or ascorbic acid on tissue accumulation and urinary excretion of 51chromium. Nutrition Research 1990;10:1401-1407.
Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem Res Toxicol 1999;12:483-7. View abstract.
Stearns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB J 1995;9:1650-7. View abstract.
Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther 2014;39(3):292-306. View abstract.
Thyssen JP, Jellesen MS, Møller P, Menné T, Johansen JD. Allergic chromium dermatitis from wearing 'chromium-free' footwear. Contact Dermatitis 2014;70(3):185-7. View abstract.
Tian H, Guo X, Wang X, He Z, Sun R, Ge S, Zhang Z. Chromium picolinate supplementation for overweight or obese adults. Cochrane Database Syst Rev 2013;11:CD010063. View abstract.
Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition. J Sports Med Phys Fitness 1995;35:273-80. View abstract.
Uusitupa MI, Kumpulainen JT, Voutilainen E, et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 1983;38:404-10. View abstract.
Uusitupa MI, Mykkanen L, Siitonen O, et al. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr 1992;68:209-16. View abstract.
Vincent JB. The biochemistry of chromium. J Nutr 2000;130:715-8. View abstract.
Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr 2001;20:293-306. View abstract.
Wang ZQ, Zhang XH, Baldor LC, et al. Chromium picolinate enhances insulin sensitivity in an animal model for the metabolic syndrome: the obese, insulin resistant JCR:LA-corpulent rat. Am Diabetes Assn's 60th Sci Sessions & Expo, San Antonio, TX 2000;Jun 9-13: abstract 291.
Wani S, Weskamp C, Marple J, Spry L. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother 2006;40:563-6. View abstract.
Wasser WG, Feldman NS, D'Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. [letter]. Ann Intern Med 1997;126:410. View abstract.
Welling R, Beaumont JJ, Petersen SJ, Alexeeff GV, Steinmaus C. Chromium VI and stomach cancer: a meta-analysis of the current epidemiological evidence. Occup Environ Med 2015;72(2):151-9. View abstract.
Wise A. Chromium supplementation and diabetes. JAMA 1978;240:2045-6. View abstract.
Yazaki Y, Faridi Z, Ma Y, et al. A pilot study of chromium picolinate for weight loss. J Altern Complement Med 2010;16:291-9. View abstract.
Yin RV, Phung OJ. Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus. Nutr J. 2015;14:14. View abstract.
Ziegenfuss TN, Lopez HL, Kedia A, et al. Effects of an amylopectin and chromium complex on the anabolic response to a suboptimal dose of whey protein. J Int Soc Sports Nutr. 2017;14:6. View abstract.
Have you ever purchased CHROMIUM?


For Amy, "our introduction to medical assistance and PCAs was really quite serendipitous." A nurse suggested that they apply for Supplemental Security Income (SSI), a federal program that Mac qualified for because he was a resident of the hospital. Once enrolled, Mac qualified for Medical Assistance (MA)—and 12 ½ hours of PCA services a day. When Mac finally came home, his SSI eligibility ended and the family learned that he could continue on MA through a state program called TEFRA. The program enables eligible children with disabilities and special health care needs to receive MA; parents may pay a fee, depending on their income.


capital district is called Yorubá Orquesta.
The revival of the real "heavy" or "angry" salsa began with La 33's first album in 2004. The Bogotá band ignored the widely popular romantic salsa and re-introduced the boogaloo and the salsa as it was played by Fania in the 1970's. Within no-time it gained an underground following of those who like their salsa as it was intended by masters like Willie Colon, Hector Lavoe and Ruben Blades.
Colombia's second largest city Medellin then followed with La Sonora 8, a band also playing salsa in a way similar to the rough form of La 33. Both bands now are considered Colombia's most important salsa bands and are frequently invited to play abroad to show what Colombia's real salsa is like.
Meanwhile, Cali did nothing. Its salsa clubs are still the most famous of Colombia and there is little doubt that the Caleños dance salsa better than anyone in Colombia, if not Latin America, but not one band was able to outgrow the city and find its way into the mountains or the northern beaches.
Yorubá Orquesta, a band that's been around since 1999 already, now is presenting its first album and will join La 33 in the war on dance floors with a more latin-jazz kind of salsa. The band puts the Colombian capital now definitely on #1 when it comes to the finest of salsa. One would almost forget that Cali is the real capital of salsa, if it still is.


It seems as if Christmas and toy delivery was just last night. As I look at the calendar, I have to face reality: Christmas and toy delivery is just eight months away.
Once again, it's time for me to collect toys for this year. In the past nine years, with the assistance of the community, we have delivered toys to over 10,000 needy children. Thank you! In November of last year, the State of Illinois finally made us a Not-For-Profit. That was too late for Christmas 2015.


text:
Q: Кодировка текста в C# (CP1163) Есть определенный код который получает и выводит листинг из БД (MySQL).
Не могу одолеть один столбец, там данные (текст) лежат в кодировке cp1163.
Соответственно в листинге отображаются кракозябры.
Знатоки, подскажите пожалуйста  как можно  штатными средствами C#  перекодировать полученное в cp1251.
Пробовал указать set names при подключении, но MySQL не понимает такой кодировки.

A: byte[] smthIn1163 = ...;
string s = new string(Encoding.GetEncoding(1163).GetChars(smthIn1163));

Ну и Encoding лучше создать один раз, а не в цикле.

A: Общий вид такой:
var sourceEncoding = Encoding.GetEncoding(1163);
var resultEncoding = Encoding.GetEncoding("windows-1251");
byte[] sourceBytes = utf8.GetBytes(text);
byte[] resultBytes = Encoding.Convert(sourceEncoding, resultEncoding, sourceBytes);
var result = resultEncoding.GetString(resultBytes);

Только вот Code Page найти я не смог. Вот спецификация на CP1163, вы можете отнаследоваться от  System.Text.Encoding и реализовать у него Convert, GetBytes.

redpajama_set_name: RedPajamaStackExchange


Describes the "adventures" of Thomas Storrow Brown (1808-1888), one of the Patriote's military leaders of the Rebellion of 1837 in Lower Canada, and his flight to Vermont following the battle at St. Denis in December 1837.
Chartier, Emile. "Après 'L'affaire Saint-Denis' : 1er-12 décembre 1837 : D'après un mémoire de Brown." Bulletin des Recherches Historiques Vol. 41, no. 4–6 (Avril-juin 1950): 130–147.


text:
Packers vs. 49ers: Follow updates from the NFC Championship game
'Morenci Nine' brought war home
6 of the 9 class of '66 graduates who enlisted were killed in Vietnam
Whitney Phillips Cronkite News Service
Dog tags from members of the Morenci Nine are among 1,800 on display at a makeshift war memorial at the top of Mares Bluff, overlooking Clifton, that was created by Vietnam veteran Stephen Guzzo.
WHITNEY PHILLIPS / CRONKITE NEWS SERVICE
Oscar Urrea
Submitted Photo Whitney Phillips
Stephen Guzzo
MORENCI - No one from this mining community thought it was out of the ordinary when nine members of the Morenci High School class of 1966 enlisted in the Marine Corps as a group during the Vietnam War.
But the community began to take notice as Marines came to town over and over to notify families that members of the group had been killed in action.
It began with Bobby Draper in August 1967. Then Stanley King, Van Whitmer, Larry West, Jose Moncayo and, finally, Clive Garcia Jr.
Only Leroy Cisneros, Mike Cranford and Joe Sorrelman came home alive.
Residents recalled funeral after funeral.
Then came national attention as outlets such as Time magazine and the Los Angeles Times arrived to tell the story of a group that came to be known as the Morenci Nine.
Spoke of returning home
Sitting in his living room in Yuma more than four decades later, Leroy Cisneros said the Morenci Nine didn't see their service as anything spectacular. They just went.
"We didn't think about it, what impact it would have," said Cisneros, who as a member of the 1st Reconnaissance Battalion scouted areas that often came under attack. "I think we were kind of naive."
They went through boot camp together in San Diego, then received different specialties and deployed to their separate stations.
Cisneros said he met up with Bobby Draper while both were in the same area for a few days in Vietnam, and they planned a grand party they wanted upon their return home.
"All we talked about was coming to Morenci," he said.
Draper was killed about a week after that when his squad was ambushed.
Cisneros said his hope now is that his friends and others who made the ultimate sacrifice are remembered.
"Don't let them be forgotten," he said. "I truly believe they all died doing something they believed in."
Cisneros is one of two living members of the Morenci Nine; Mike Cranford passed away 2007.
Marshall Trimble, Arizona's state historian, said while many from rural areas serve, the story of the Morenci Nine stands out because so many of them didn't come home. He said groups of small-town warriors like the nine are a tough loss because of their potential.
"Some of the best are the ones who feel obligated to serve, and it's a noble calling," he said. "When they don't come home, think what they might have become."
Preserving their legacy
Oscar Urrea, who grew up with the Morenci Nine and served in Vietnam with the Army, stands next to a hillside road, pointing out where he and the others played football at Morenci High School.
But the field, the high school and the old town's other buildings are gone now, torn down and replaced by an open pit as the copper mine expanded and Phelps Dodge moved the town.
"All we have is a memory of our little town," he said.
Urrea traveled from his home in Gilbert to take a reporter on a tour of Morenci. He highlighted places significant to the nine.
There's a plaque bearing their names at the relocated Morenci High School. Clive Garcia's grave lies among other veterans' in Bunkers Cemetery.
At the top of Mares Bluff, overlooking Clifton, fellow Vietnam veteran Stephen Guzzo has created a memorial, which he calls the Long Walk for Freedom. It includes flags, a fallen soldier's cross and a string of more than 1,800 dog tags to honor all who serve. The first six honor those killed among the Morenci Nine.
Names from the nine are among those on a plaque dedicated to the 12 area residents who died in Vietnam. A Bible resting in a wooden box with a cross signifies the importance of faith, and another box has a book filled with visitors' comments.
"Made it up here and thought it would never be possible, but found my grandpa's tag," one read.
Guzzo, who served in the Army, said it was important for him to pay respects to the Morenci Nine because their group suffered an extraordinary loss.
"What brought it home, what made the impact," he said, "was the Morenci Nine."
The memorial, however, is about all who have served, Guzzo said.
"We can't forget our other people, either."
The Morenci 9
• Cpl. Bobby Draper, killed in action (1967)
• Lance Cpl. Stanley King, killed in action (1967)
• Lance Cpl. Van Whitmer, killed in action (1968)
• Lance Cpl. Larry West, killed in action (1968)
• Sgt. Jose Moncayo, killed in action (1968)
• Sgt. Clive Garcia Jr., killed in action (1969)
• Sgt. Leroy Cisneros, survived the war
• Cpl. Mike Cranford, survived the war
• Cpl. Joe Sorrelman, survived the war
US Rep Kirkpatrick from Tucson to seek alcohol treatment after serious fall in D.C.
Congresswoman suffered several cracked ribs and spinal fractures; cannot vote on House bills during her absence.
Bird lovers open up about death traps hidden all around us
U.S. Fish and Wildlife Service employee Emily Clark said she never really noticed the pipe problem until she started researching its tragic impact on birds and other animals.
Tucson police to quit taking funds from federal border-security grant
The Tucson Police Department says the Operation Stonegarden grant, which reimburses local municipalities for costs associated with policing border security, conflicts with its mission.
Sen. Martha McSally calls CNN reporter 'liberal hack' after impeachment question
Sen. Martha McSally dismissed a CNN reporter as a "liberal hack" on Thursday when he tried to ask her about President Donald Trump's upcoming impeachment trial.
Authorities ID man found dead Sunday in Tucson apartment complex
The Pima County Sheriff's Department responded to the complex in the 7300 block of North Mona Lisa Road about 11:30 p.m. Sunday.
Family, friends remember Tucson pilot killed in terror attack as loving father, husband
Dustin Scott Harrison was nine days away from coming home to his wife and 2-year-old daughter when he was killed in an attack by the al-Shabab…
Gunman gets life term in 'Fast and Furious' killing of Border Patrol agent
Seven men have been charged in the 2010 slaying; five already serving prison terms.
Crime-and-courts
Court to decide if man will face trial in fatal shooting during a pickup basketball game
Paul Alvarez Sr. told police he shot and killed a man who had punched his son during a pickup game outside a Tucson church. But a doctor says he's incompetent to stand trial.
Mine Tales: Early years of the Clifton-Morenci mining district
The Clifton-Morenci mining district in eastern Arizona has a long history of mineral production.
U.S. Rep. Kirkpatrick says she is getting treatment for alcohol dependency after serious fall
Congresswoman suffered multiple cracked ribs and spinal fractures in fall last week.